Zobrazeno 1 - 10
of 136
pro vyhledávání: '"McKeage, Mark J."'
Publikováno v:
In Cancer Epidemiology December 2018 57:24-32
Autor:
Cui, Haigang, Zhang, Anna J., McKeage, Mark J., Nott, Louise M., Geraghty, Dominic, Guven, Nuri, Liu, Johnson J.
Publikováno v:
In Journal of Inorganic Biochemistry December 2017 177:249-258
Autor:
McKeage, Mark J.
Publikováno v:
In Clinical Lung Cancer May 2011 12(3):143-147
Autor:
McKeage, Mark J., Reck, Martin, Jameson, Michael B., Rosenthal, Mark A., Gibbs, David, Mainwaring, Paul N., Freitag, Lutz, Sullivan, Richard, Von Pawel, Joachim
Publikováno v:
In Lung Cancer 2009 65(2):192-197
Autor:
Liu, Johnson J., Galettis, Peter, Farr, Alistair, Maharaj, Lenushka, Samarasinha, Hasitha, McGechan, Adam C., Baguley, Bruce C., Bowen, Richard J., Berners-Price, Susan J., McKeage, Mark J.
Publikováno v:
In Journal of Inorganic Biochemistry 2008 102(2):303-310
Publikováno v:
In Journal of Chromatography B 2006 837(1):29-34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
McKeage Mark J, Jameson Michael B, Ramanathan Ramesh K, Rajendran Joseph, Gu Yongchuan, Wilson William R, Melink Teresa J, Tchekmedyian N
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 496 (2012)
Abstract Background The purpose of this phase Ib clinical trial was to determine the maximum tolerated dose (MTD) of PR-104 a bioreductive pre-prodrug given in combination with gemcitabine or docetaxel in patients with advanced solid tumours. Methods
Externí odkaz:
https://doaj.org/article/075b31c154344b5aab6a4555bbaa90f2
Autor:
Amies Karen, Hill Andrew, Wilson William R, Gu Yongchuan, McKeage Mark J, Melink Teresa J, Jameson Michael B
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 432 (2011)
Abstract Background The phosphate ester PR-104 is rapidly converted in vivo to the alcohol PR-104A, a nitrogen mustard prodrug that is metabolised to hydroxylamine (PR-104H) and amine (PR-104M) DNA crosslinking agents by one-electron reductases in hy
Externí odkaz:
https://doaj.org/article/d2c3a3579d074af3a69897eb9abdeb8f
Publikováno v:
Molecular Pain, Vol 6, Iss 1, p 53 (2010)
Abstract Background ATP7A, ATP7B and CTR1 are metal transporting proteins that control the cellular disposition of copper and platinum drugs, but their expression in dorsal root ganglion (DRG) tissue and their role in platinum-induced neurotoxicity a
Externí odkaz:
https://doaj.org/article/3f167d82d3e1468ebf3c7055b4c3527a